Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Liotta, NJ

Fina Liotta, Westfield, NJ US

Patent application numberDescriptionPublished
20090099143TETRAHYDRO-INDAZOLE CANNABINOID MODULATORS - This invention is directed to a tetrahydro-indazole cannabinoid modulator compound of formula I:04-16-2009
20090197886HEXAHYDRO-CYCLOHEPTAPYRAZOLE CANNABINOID MODULATORS - This invention is directed to a hexahydro-cycloheptapyrazole cannabinoid modulator compound of formula (I):08-06-2009
20100069341TETRAHYDRO-PYRANOPYRAZOLE CANNABINOID MODULATORS - This invention is directed to a tetrahydro-pyranopyrazole cannabinoid modulator compound of formula (I):03-18-2010
20100234331HEXAHYDRO-CYCLOOCTYL PYRAZOLE CANNABINOID MODULATORS - This invention is directed to a hexahydro-cyclooctyl pyrazole cannabinoid modulator compound of formula (I):09-16-2010
20100279991TETRAHYDRO-CYCLOPENTYL PYRAZOLE CANNABINOID MODULATORS - This invention is directed to a tetrahydro-cyclopentyl pyrazole cannabinoid modulator compound of formula (I):11-04-2010
20100317633HEXAHYDRO-CYCLOOCTYL PYRAZOLE CANNABINOID MODULATORS - This invention is directed to a hexahydro-cyclooctyl pyrazole cannabinoid modulator compound of formula (I):12-16-2010

Patent applications by Fina Liotta, Westfield, NJ US

Vincenzo Liotta, Glen Ridge, NJ US

Patent application numberDescriptionPublished
20080254128Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same - The present invention provides a method of continuous precipitation and isolation of an amorphous solid particulate form of 3-[2-(3-tert-Butyl-ureido)-3,3-dimethyl-butyryl]-6,6-dimethyl-3-aza-bicyclo[3.1.0]hexane-2-carboxylic acid (2-carbamoyl-1-cyclobutylmethyl-2-oxo-ethyl)-amide having controlled physical properties. The present invention provides also pharmaceutical formulations comprising the precipitated compound.10-16-2008
20100249439PROCESS FOR CONTROLLED CRYSTAL SIZE IN 1,2-SUBSTITUTED 3,4-DIOXO-1-CYCLOBUTENE COMPOUNDS - This application discloses a novel process for the preparation of 2-Hydroxy-N,N-dimethyl-3-[[2-[[1(R)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamide, which has utility, for example, in the treatment of CXC chemokine-mediated diseases.09-30-2010